30 /100
MEDIUM RISK
Score updated May 30, 2026

HBIO — Harvard Bioscience, Inc. Dilution Risk Tracker

Track HBIO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track HBIO — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
50
💰 Cash Runway
0
📊 Float Risk
30
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

Watch
Minor dilution signals detected
14%
💰 Capital Raise 20%
• Active shelf registration ($8M, 28% of market cap)
📉 Score Deterioration 15%
• Score climbed 8 points (worsening)
🔔 Track HBIO — Get forecast alerts →

💹 Market Data

Market Cap$26.52M
Shares Outstanding4.51M
Float3.53M
Cash$7.10M
Debt$44.12M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 2.4% shares (2025Q4 vs prior)
63 institutional holders · 17.67M shares
#1 WEBER CAPITAL MANAGEMENT LLC /ADV 3.20M shares
#2 VANGUARD GROUP INC 1.92M shares
#3 ACADIAN ASSET MANAGEMENT LLC 1.77M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest120.9K
Days to Cover3.4
% of Float3.4%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
4 INSIDER TRANSACTION Mar 23, 2026
4 INSIDER TRANSACTION Mar 18, 2026
4 INSIDER TRANSACTION Mar 18, 2026
4 INSIDER TRANSACTION Mar 17, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track HBIO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking HBIO — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for HBIO
📊 HBIO FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 HBIO Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.